...
首页> 外文期刊>Intensive care medicine >Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
【24h】

Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.

机译:精氨酸加压素和特立加压素在羊源性败血性休克中作为一线血管加压药的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To compare the effects of first-line therapy with low-dose arginine vasopressin (AVP) or terlipressin (TP) on mesenteric blood flow, plasma AVP levels, organ function and mortality in ovine septic shock. METHODS: Twenty-four adult ewes were anesthetized and instrumented for chronic hemodynamic monitoring. A flow-probe was placed around the superior mesenteric artery, and feces were extracted from the cecum. Following baseline measurements, feces were injected into the peritoneal cavity. When mean arterial pressure (MAP) decreased to less than 60 mmHg, animals were randomly assigned to receive AVP (0.5 mU kg(-1) min(-1)), TP (1 microg kg(-1) h(-1)) or saline (n = 8 each). A norepinephrine infusion was titrated to maintain MAP at 70 +/- 5 mmHg in all groups. RESULTS: Cardiovascular pressures, cardiac output, mesenteric blood flow, and lung tissue concentrations of 3-nitrotyrosine and hemoxygenase-1 were similar among groups throughout the study period. TP infusion resulted in lower plasma AVP concentrations, reduced positive net fluid balance, increased central venous oxygen saturation and slightly prolonged survival compared to control and AVP-treated animals. However, TP treatment was associated with higher liver transaminases and lactate dehydrogenase versus control animals after 12 h. CONCLUSIONS: This study provides evidence that the effects of low-dose TP differ from those of AVP, not only as TP has a longer half life, but also because of different mechanisms of action. Although low-dose TP infusion may be superior to sole norepinephrine or AVP therapy in septic shock, the safety of this therapeutic approach should be determined in more detail.
机译:目的:比较一线疗法与小剂量精氨酸加压素(AVP)或特利加压素(TP)对羊败血性休克肠系膜血流,血浆AVP水平,器官功能和死亡率的影响。方法:麻醉24只成年母羊,并对其进行慢性血流动力学监测。将流探针放置在肠系膜上动脉周围,并从盲肠中提取粪便。在基线测量后,将粪便注入腹膜腔。当平均动脉压(MAP)降至小于60 mmHg时,将动物随机分配以接受AVP(0.5 mU kg(-1)min(-1)),TP(1 microg kg(-1)h(-1) )或生理盐水(每组n = 8)。在所有组中滴定去甲肾上腺素的输注量以将MAP维持在70 +/- 5 mmHg。结果:在整个研究期间,各组的心血管压力,心输出量,肠系膜血流量以及肺组织中的3-硝基酪氨酸和血氧合酶-1浓度相似。与对照组和经AVP处理的动物相比,TP输注可降低血浆AVP浓度,降低正净液平衡,增加中心静脉血氧饱和度并略微延长生存期。然而,与对照动物相比,TP治疗与12h后更高的肝脏转氨酶和乳酸脱氢酶相关。结论:这项研究提供了证据,证明低剂量TP的效果不同于AVP,不仅因为TP具有更长的半衰期,而且还因为其不同的作用机理。尽管在感染性休克中低剂量TP输注可能优于单独的去甲肾上腺素或AVP治疗,但应更详细地确定这种治疗方法的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号